SaveHealth explores the historical trajectory of weight loss drugs, examining their scientific basis, regulatory battles, public reception, and what lies ahead for pharmacotherapy in obesity ...

The Russian authorities on Monday outlawed Amnesty International as an “undesirable organization,” a label that under a 2015 law makes involvement with such organizations a criminal offense. The ...

Asian shares fell Monday and U.S. futures and the dollar weakened after Moody’sRatings downgraded the sovereign credit rating for the United States because of its failure to stem a ...

Danone has introduced a new protein shake under its Oikos yogurt brand as rivals Fairlife and Chobani that have similar ...

You’ve probably heard the stories: For every man who has cut carbs from his diet and dropped 10 pounds, there’s a woman who’s ...

LONDON (Reuters) -Wegovy-maker Novo Nordisk said on Friday its CEO Lars Fruergaard Jorgensen will step down over concerns the ...

President Donald Trump told Fox News host Sean Hannity that the pal who starred in the "fat shot" story was "very worried" Trump would "slip" and reveal his name to the world. Trump has been ...

The findings come after reports of nasty side effects - including eye problems, infections and gastrointestinal disorders - ...

President Trump said he would sign an executive order to base U.S. drug prices on what other countries pay — usually far less ...

(Reuters) -Eli Lilly said on Sunday its drug Zepbound was superior to Novo Nordisk's Wegovy across five weight-loss targets such as reducing waist circumference, citing data from a head-to-head trial.

It was spurred by the Intercept’s disclosure of Musk’s hitherto-secret White House email address: [email protected]. When the Intercept first published Musk’s email address, on March 6, journalist ...

Shares of Novo Nordisk climbed nearly 7% on Wednesday after the company said sales of its obesity drug Wegovy are expected to ...